Multidrug-Resistant Acinetobacter baumannii Osteomyelitis from Iraq

Multidrug-Resistant Acinetobacter baumannii Osteomyelitis from Iraq

Bibliographic Details
Main Authors:	Jason J. Schafer, Julie E. Mangino
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2008-03-01
Series:	Emerging Infectious Diseases
Subjects:	Acinetobacter baumannii tigecycline osteomyelitis multidrug resistance letter Iraq
Online Access:	https://wwwnc.cdc.gov/eid/article/14/3/07-0128_article

Similar Items

Comparison of minimal inhibitory concentrations (MICs) of tigecycline in 2011 and 2015 years against multidrug-resistance acinetobacter baumannii strains
by: Yucel Duman, et al.
Published: (2017-03-01)

Two Cases Report of Intrathecal Tigecycline Therapy for Intracranial Infection with Acinetobacter baumannii and Review of Literatures
by: Huang G, et al.
Published: (2022-04-01)

Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: A Case Report and Review of Literature
by: Wenyong Long, et al.
Published: (2018-06-01)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
by: Chunli Sun, et al.
Published: (2023-05-01)

Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii
by: Xing Lan, et al.
Published: (2024-03-01)

Tigecycline Suppresses the Virulence Factors of Multidrug-Resistant Acinetobacter baumannii Allowing Human Neutrophils to Act
by: Sato Y, et al.
Published: (2022-06-01)

Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii
by: Hasan Ghajavand, et al.
Published: (2017-01-01)

Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
by: Yangang Zhou, et al.
Published: (2019-04-01)

Acinetobacter baumannii: an evolving and cunning opponent
by: Jingchao Shi, et al.
Published: (2024-01-01)

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
by: Jeongwoo Jo, et al.
Published: (2021-10-01)

Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant Acinetobacter baumannii
by: Nisha Rathor, et al.
Published: (2023-01-01)

Factors influencing survival in patients with multidrug-resistant Acinetobacter baumannii infection
by: Mariana Lima Prata-Rocha, et al.

Epidemiological characteristics of multidrug-resistant Acinetobacter baumannii ST369 in Anhui, China
by: Yi Huang, et al.
Published: (2023-10-01)

Molecular typing and antibiotic resistance patterns among clinical isolates of Acinetobacter baumannii recovered from burn patients in Tehran, Iran
by: Abbas Maleki, et al.
Published: (2022-10-01)

Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin
by: Yu-Mu Chen, et al.
Published: (2014-10-01)

Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia
by: Jiawei Zeng, et al.
Published: (2017-08-01)

Multidrug-Resistant Acinetobacter baumannii
by: Aharon Abbo, et al.
Published: (2005-01-01)

In vitro activity of tigecycline against clinical isolates of carbapenem resistant <it>Acinetobacter baumannii</it> complex in Pretoria, South Africa
by: Ahmed Nahid H, et al.
Published: (2012-05-01)

A bronchofiberoscopy-associated outbreak of multidrug-resistant <it>Acinetobacter baumannii</it> in an intensive care unit in Beijing, China
by: Xia Yukun, et al.
Published: (2012-12-01)

Prolonged and high dosage of tigecycline – successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report
by: Olga Tsachouridou, et al.
Published: (2017-07-01)

Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients
by: Jiangang Zhang, et al.
Published: (2022-02-01)

Investigation of Tigecycline Susceptibility of Multidrug-Resistant Acinetobacter Baumannii Isolates by Disc Diffusion, Agar Gradient and Broth Microdilution Tests
by: Emel Çalışkan, et al.
Published: (2022-01-01)

Genotypic patterns of multidrug-resistant Acinetobacter baumannii: A systematic review
by: Golnar Rahimzadeh, et al.
Published: (2023-01-01)

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018)
by: Harald Seifert, et al.
Published: (2022-12-01)

Antibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii
by: Banoub NG, et al.
Published: (2021-08-01)

Relative Gene Expression of RND-Type Efflux Pumps in Tigecycline Resistant Acinetobacter Baumannii Isolated from Training Hospitals in Tehran, Iran
by: Mina Owrang, et al.
Published: (2018-12-01)

Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report
by: Haiyan Xing, et al.
Published: (2021-07-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Molecular Characterization of Multiple Antibiotic-Resistant Acinetobacter baumannii Isolated from Egyptian Patients
by: Aya A. Khodier, et al.
Published: (2020-12-01)

Investigation of the Characteristics of Multidrug-Resistant (MDR) Acinetobacter Baumannii Lytic Phage Isolated from the Intensive Care Unit
by: Behnam Sisakhtpour, et al.
Published: (2019-08-01)

Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China
by: Kaihang Yu, et al.
Published: (2021-01-01)

High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit
by: Bai XR, et al.
Published: (2020-05-01)

Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Gu S, et al.
Published: (2023-05-01)

Glabridin Functions as a Quorum Sensing Inhibitor to Inhibit Biofilm Formation and Swarming Motility of Multidrug-Resistant Acinetobacter baumannii
by: Lin H, et al.
Published: (2023-08-01)

Genomic analysis of extensively drug-resistant Acinetobacter baumannii harbouring a conjugative plasmid containing aminoglycoside resistance transposon TnaphA6
by: Satoshi Nishida, et al.
Published: (2024-02-01)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
by: Liping Li, et al.
Published: (2020-10-01)

Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain
by: Joshi Acosta, et al.
Published: (2011-06-01)

Prevalence of OXA genes responsible for carbapenem-resistance among Acinetobacter baumannii isolated from clinical samples in Iraq
by: Jawad R Alzaidi
Published: (2023-01-01)

Acinetobacter baumannii in suspected bacterial infections: Association between multidrug resistance, virulence genes, & biofilm production
by: Deepan Gautam, et al.
Published: (2023-01-01)

iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii
by: Ni Yang, et al.
Published: (2018-11-01)